Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,959 | 387,878 | 397,451 | 834,657 | 68,985 |
| Marketable Securities | 1,387,000 | 1,359,330 | 682,776 | 96,719 | 176,985 |
| TOTAL | $1,627,361 | $1,787,985 | $1,095,954 | $942,555 | $256,348 |
| Non-Current Assets | |||||
| PPE Net | 257,370 | 198,045 | 79,626 | 10,360 | 7,954 |
| Investments And Advances | 881,664 | 1,387,510 | 162,675 | 26,549 | 27,117 |
| Other Non-Current Assets | 236,322 | 137,778 | 69,662 | 26,714 | 32,918 |
| TOTAL | $1,375,356 | $1,723,333 | $311,963 | $63,623 | $67,989 |
| Total Assets | $3,002,717 | $3,511,318 | $1,407,917 | $1,006,178 | $324,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70,904 | 48,452 | 14,587 | 9,795 | 6,758 |
| Accrued Expenses | 31,068 | 29,123 | 59,815 | 15,375 | 8,787 |
| TOTAL | $205,750 | $140,180 | $145,338 | $40,525 | $28,716 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 111,457 | 65,319 | 22,111 | 12,040 | 11,603 |
| TOTAL | $111,457 | $65,319 | $22,111 | $12,040 | $11,603 |
| Total Liabilities | $317,207 | $205,499 | $167,449 | $52,565 | $40,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,920 | 128,762 | 108,408 | 80,034 | 56,311 |
| Common Shares | 134 | 128 | 98 | 82 | 56 |
| Retained earnings | -2,154,947 | -1,388,319 | -924,392 | -522,126 | -298,641 |
| Other shareholders' equity | 1,587 | -3,873 | 179 | -361 | -241 |
| TOTAL | $2,685,510 | $3,305,819 | $1,240,468 | $953,613 | $284,018 |
| Total Liabilities And Equity | $3,002,717 | $3,511,318 | $1,407,917 | $1,006,178 | $324,337 |